The draft Preferential Procurement Regulations (“the draft regulations”) were published for public comment on 14 August 2009. The AIDS Law Project (ALP), a not-for-profit organisation that seeks to use and develop the law to defend and advance constitutionally protected rights, has a direct interest in the draft regulations. This arises out of ALP’s work on access to medicines – an integral part of the right to have access to health care services – and the manner in which the state procures antiretroviral (ARV) medicines. ALP has submitted a document with recommendations in respect to the...Read more
By Mark Heywood, Director of the AIDS Law Project
Last week the great and good of the South African private health industry and the national Health Department gathered for four days at Sun City to deliberate on the future of health care and the proposed system of National Health Insurance (NHI). They started their conference with a golf day and ended with a banquet, dress: ‘black tie or traditional’. Whilst the pro- and not-so-sure NHI’ers differed on the conference floor, they mixed easily on the dance floor.
Intense debates about the future health system took place, with...Read more
GlaxoSmithKline (GSK), one of the world's largest pharmaceutical developers, and Aspen Pharmacare, South Africa's largest generic pharmaceutical manufacturer, intend to merge their South African operations. As part of the merger, most of GSK's South African operations will become part of Aspen. GSK will purchase 16% of Aspen's shares and become the company's single-largest shareholder.
Following submissions and correspondence from the Treatment Action Campaign (TAC), the Centre for the AIDS Programme of Research (CAPRISA) and the Southern African HIV Clinicians Society (SAHCS),...Read more
Almost a year subsequent to the last ART moratorium in the Free State, during which the HIV Clinicians Society estimated that an additional thirty people a day died from AIDS due to their inability to access antiretroviral treatment (ART), the CEO of the province’s HIV programme has stated that another moratorium is likely to be implemented this month.
It is government’s responsibility to make ART accessible and sustainable, as stated in the National Strategic Plan (NSP), to which government has committed. The NSP aims to treat 80% of people who need ART by 2011, and to reduce HIV...Read more
The Advertising Standards Authority of Southern Africa (ASASA) ruled that advertising of the herbal supplement Revivo must be withdrawn in South Africa. Revivo advertising made unsubstantiated and misleading claims that the product works as a treatment for HIV. The ASASA ruling was made in response to a consumer complaint lodged by Patrick Linzer.
TAC is very grateful to Mr. Linzer for making the compliant against Aconite Medical Suppliers cc, the company that produces Revivo. Aconite Medical Suppliers cc has been misleading consumers in order to make a profit.